Literature DB >> 15932483

The evaluation of a model of primary mental health care in rural Tasmania.

Alistair Campbell1.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the effectiveness of a primary care mental health service.
DESIGN: The study used a naturalistic longitudinal design to follow groups of participants who received intervention from a rural mental health worker, or 'usual' mental health service, or no treatment, over a period of 12 months.
SETTING: The service was evaluated in a rural primary care setting. PARTICIPANTS: One hundred and forty-five primary care patients. OUTCOME MEASURES: Changes in symptomatology were assessed using the SCL-90R summary scales, and changes in quality of life were assessed using the EuroQOL.
RESULTS: Those participants treated by the primary mental health worker showed significant improvements in symptoms and quality of life compared to both the usual and no-treatment groups.
CONCLUSION: There are few studies evaluating mental health services in rural settings. This study demonstrated that a particular model of primary mental health care was more effective than usual mental health care and no treatment at resolving symptoms and improving quality of life.

Entities:  

Mesh:

Year:  2005        PMID: 15932483     DOI: 10.1111/j.1440-1854.2005.00694.x

Source DB:  PubMed          Journal:  Aust J Rural Health        ISSN: 1038-5282            Impact factor:   1.662


  2 in total

1.  Clinicians' and patients' views of metrics of change derived from patient reported outcome measures (PROMs) for comparing providers' performance of surgery.

Authors:  Zoe Hildon; Jenny Neuburger; Dominique Allwood; Jan van der Meulen; Nick Black
Journal:  BMC Health Serv Res       Date:  2012-06-21       Impact factor: 2.655

Review 2.  Primary health care delivery models in rural and remote Australia: a systematic review.

Authors:  John Wakerman; John S Humphreys; Robert Wells; Pim Kuipers; Philip Entwistle; Judith Jones
Journal:  BMC Health Serv Res       Date:  2008-12-29       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.